Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Kahook Dual Blade Goniotomy versus Trabecular Micro-bypass stent (iStent inject): Surgical Outcomes in the Minimally Invasive Treatment of Glaucoma in Combination with Phacoemulsification
Author Affiliations & Notes
  • Kevin Yang Wu
    Ophthalmology, Hotel-Dieu de Sherbrooke, Sherbrooke, Quebec, Canada
  • Gauri Patel
    Medicine, Universite de Montreal, Montreal, Quebec, Canada
  • Marchand-Gareau Michaël
    Ophthalmology, Hotel-Dieu de Sherbrooke, Sherbrooke, Quebec, Canada
  • Footnotes
    Commercial Relationships   Kevin Yang Wu None; Gauri Patel None; Marchand-Gareau Michaël None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4259. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kevin Yang Wu, Gauri Patel, Marchand-Gareau Michaël; Kahook Dual Blade Goniotomy versus Trabecular Micro-bypass stent (iStent inject): Surgical Outcomes in the Minimally Invasive Treatment of Glaucoma in Combination with Phacoemulsification . Invest. Ophthalmol. Vis. Sci. 2023;64(8):4259.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Controversy exists regarding the efficacy and safety of Kahook Blade Dual (KDB) goniotomy compared to that of a second-generation trabecular micro-bypass stent (iStent inject) in combination with cataract extraction. We performed a retrospective, single-center, observational, longitudinal case series to compare the efficacy and safety of these two types of microinvasive glaucoma surgery (MIGS), as existent literature comparing MIGS procedure head-to-head is limited.

Methods : All participants undergoing either of the MIGS procedure were included in our study. The intervention was combined with elective cataract extraction. Data collection included IOP, IOP-lowering medications and best-correct visual acuity (BCVA) preoperatively and at 1 day, 2 weeks, 1 month, 6 months and 12 months postoperatively. In addition, intraoperative and postoperative adverse events were also examined. The primary efficacy outcome was the proportion of patients in each group attaining 20% reduction of IOP. Subgroup analysis were conducted for different types of glaucoma.

Results : A total of 29 patients (49 eyes) were included in the iStent inject group and 16 patients (22 eyes) in the KDB group. Mean follow-up was 6 months for both groups. Pre- and post-operative IOPs were 23.68 ± 6.06 mmHg and 12.8 ± 2.4 mmHg (P <0.0001) in the Phaco-KDB group as well as 21.51 ± 4.99 mmHg and 15 ± 1.91 mmHg (P <0.0001) in the Phaco-iStent inject group. No major complications occurred. Changes in IOP and medications were not significantly different between groups (P>0.05).

Conclusions : KDB and iStent inject showed clinically significant IOP-lowering effect when combined with phacoemulsification. The IOP reduction by Phaco-KDB was equivalent to that by Phaco-iStent inject.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Table 1: Comparison of post-operative intraocular pressure change

Table 1: Comparison of post-operative intraocular pressure change

 

Figure 2: Average of post-operative intraocular pressure change (two groups combined)

Figure 2: Average of post-operative intraocular pressure change (two groups combined)

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×